ArticleiScience2025
The association between cystatin C and hypertension risk in diabetes patients: A multi-cohort cross-sectional study.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus with hypertension (DM + HTN) markedly elevates cardiovascular risks, yet its predictors remain unclear. Analyzing 5210 DM patients from three cohorts, this study identified serum cystatin C (CysC) as an independent risk factor for DM + HTN through univariate and multivariate logistic regression. A risk prediction model incorporating CysC concentration was developed and adjusted for age, sex, race, education, body mass index, smoking status, and drinking status. The model demonstrated good predictive performance and net benefit through receiver operating characteristic curves, calibration curves, and decision curve analysis. Restricted cubic spline analysis demonstrated a nonlinear relationship between CysC levels and DM + HTN risk, with concentrations above 0.94 mg/L exhibiting elevated risk. The model's performance was further evaluated using 10 machine learning algorithms and interpreted using SHapley Additive exPlanations (SHAP). This research provides a CysC-based model to aid clinicians in early identification of high-risk individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.